Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions

Clinical and Experimental Immunology

Volumn 144, Issue 3, 2006, Pages 512-520

  Harboe, M ^a   Garred, P ^b   Borgen, M S ^a   Stahl, G L ^c   Roos, A ^d   Mollnes, T E ^a,e  

^a UNIVERSITY OF OSLO   (Norway)

^b Mental Health Services CPH   (Denmark)

^c HARVARD MEDICAL SCHOOL   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Alternative pathway; Autoimmunity; Complement; Inflammation; Lectin pathway; Mannose binding lectin

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; MANNAN; MANNOSE BINDING LECTIN; MONOCLONAL ANTIBODY; TERMINAL COMPLEMENT COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEPOSITION; COMPLEMENT LECTIN PATHWAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HOMOZYGOSITY; HUMAN; INFLAMMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SERUM; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; COMPLEMENT C1Q; COMPLEMENT C2; COMPLEMENT C4; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; HUMANS; MANNANS; MANNOSE-BINDING LECTIN; SERUM;

EID: 33744461802     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03072.x     Document Type: Article

References (39)

1. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 2004 138 : 439 46.
2. Matsushita M, Fujita T. Ficolins and the lectin complement pathway. Immunol Rev 2001 180 : 78 85.
3. Roos A, Bouwman LH, Munoz J et al. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 2003 39 : 655 68.
4. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC. L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 2004 279 : 47513 9.
5. Zhao H, Wakamiya N, Suzuki Y, Hamonko MT, Stahl GL. Identification of human mannose binding lectin (MBL) recognition sites for novel inhibitory antibodies. Hybridoma Hybridomics 2002 21 : 25 36.
6. Collard CD, Väkevä A, Morrissey MA et al. Complement activation after oxidative stress. Role of the lectin complement pathway. Am J Path 2000 156 : 1549 56.
7. McGrath FDG, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol 2006 176 : 2950 7.
8. Harboe M, Closs O, Reitan LJ, Draper P. Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7. Int J Leprosy 1981 49 : 147 58.
9. Gaylord H, Brennan PJ, Young DB, Buchanan TM. Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun 1987 55 : 2860 3.
10. Garred P, Harboe M, Oettinger T, Kock C, Svejgaard A. Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 1994 21 : 125 31.
11. Seelen MA, Roos A, Wieslander J et al. Functional analysis of the classical, alternative and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Meth 2005 296 : 187 98.
12. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003 40 : 73 84.
13. Larsen F, Madsen HO, Sim RB, Koch C, Garred P. Disease-associated mutations in human mannose-binding lectin compromise oligomerisation and activity of the final protein. J Biol Chem 2004 279 : 21302 11.
14. Mollnes TE, Lea T, Frøland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoepitope of the complex. Scand J Immunol 1985 22 : 197 202.
15. Wagner E, Platt JL, Howell DN, Marsh HC Jr., Frank MM. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass in a guinea pig model. J Immunol 1999 163 : 3549 58.
16. Yount WJ, Dorner MM, Kunkel HG, Kabat EA. Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med 1968 127 : 633 46.
17. Kondori N, Edebo L, Mattsby-Baltzer I. Circulating β (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis. Clin Diagn Laboratory Immunol 2004 11 : 344 50.
18. Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC. An assay for the mannan-binding lectin pathway of complement activation. J Immunol Meth 2001 257 : 107 16.
19. Thiel S, Møller-Kristensen M, Jensen L, Jensenius JC. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 2002 205 : 446 54.
20. Roos A, Garred P, Wildenberg ME et al. Antibody-mediated activation of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 2004 34 : 2589 98.
21. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003 40 : 423 9.
22. Casanova J-L, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J Exp Med 2004 199 : 1295 9.
23. Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 2006 43 : 86 96.
24. Bouwman LH, Roos A, Terpstra OT et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005 129 : 408 14.
25. Walport JM. Advances in immunology: complement - first of two parts. New Engl J Med 2001 344 : 1058 66.
26. Mollnes TE, Song W-C, Lambris JD. Complement in inflammatory tissue damage and disease. Trends Immunol 2002 23 : 61 4.
27. Matsuda M, Shikata K, Wada J et al. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron 1998 80 : 408 13.
28. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T. Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis. Am J Kidney Dis 2000 35 : 401 7.
29. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transpl 1998 13 : 1984 90.
30. Roos A, Bouwman LH, van Gijlswijk-Janssen DL, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001 167 : 2861 8.
31. Chan RK, Ibrahim SI, Verna N, Carroll M, Moore FD Jr., Hechtman HB. Ischaemia-reperfusion is an event triggered by immune complexes and complement. Br J Surg 2003 90 : 1470 8.
32. Fiane AE, Videm V, Lingaas PS et al. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 2003 108 : 849 56.
33. Zhang M, Austen WG Jr., Chiu I et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA 2004 101 : 3886 91.
34. Hart ML, Ceonzo KA, Shaffer LA et al. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 2005 174 : 6373 80.
35. Møller-Kristensen M, Wang W, Ruseva M et al. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 2005 61 : 426 34.
36. Walsh MC, Bourcier T, Takahashi K et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005 175 : 541 6.
37. Weiser MR, Williams JP, Moore FD Jr. et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996 183 : 2343 8.
38. Williams JP, Pechet TT, Weiser MR et al. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 1999 86 : 938 42.
39. Stahl GL, Xu Y, Hao L et al. Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 2003 162 : 449 55.